Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer

Survival rates in patients with stage IIIA non-small cell lung cancer (NSCLC) remain low despite curative treatment. This is due to tumor recurrence at distant sites. The aim of neoadjuvant chemotherapy (NA-CT) is to eradicate occult micrometastatic disease and improve survival in patients that are...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: Palka, Magda, Sanchez, Antonio, Córdoba, Mar, Nuevo, Gema Díaz, De Ugarte, Andrés Varela, Cantos, Blanca, Méndez, Miriam, Calvo, Virginia, Maximiano, Constanza, Provencio, Mariano
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2017
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403378/
https://ncbi.nlm.nih.gov/pubmed/28454304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5620
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi